Engineered cardiac tissues generated using Tara Biosystems' heart-on-a-chip system predict how patients will respond to a range of drugs, as demonstrated in a recent study with GSK.
TARA Biosystems is a New York-based biotechnology firm that develops stem cell and tissue engineering platforms for drug discovery and translational medicine applications.